溢多利(300381.SZ):第四季度“溢利轉債”完成轉股1051.6313萬股
格隆匯1月3日丨溢多利(300381.SZ)公佈,溢利轉債(債券代碼:123018)轉股期限為2019年6月26日至2024年12月20日,最新有效的轉股價格為人民幣8.35元/股。
2019年第四季度,共有878,124張“溢利轉債”完成轉股(票面金額共計8781.24萬元人民幣),合計轉為1051.6313萬股“溢多利”股票(股票代碼:300381)。
截至2019年第四季度末,公司剩餘可轉債為388.69萬張,剩餘票面總金額為3.8869億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.